Anti HER2 ScFv-GFP融合抗体靶向检测HER2的表达

为验证真核表达的携带绿色荧光的抗HER2单链抗体应用于临床诊断HER2阳性肿瘤细胞和病理组织的可靠性,构建融合基因Anti HER2 ScFv-GFP,重组入pFAST Bac HT A载体,在昆虫细胞Sf9中表达,以Ni2+-NTA亲和层析法纯化Anti HER2 ScFv-GFP融合蛋白,测定其浓度与纯度,将同浓度的纯化蛋白分别与3种乳腺癌细胞BT474、SKBR3和MCF7各混合12 h、24 h和48 h,分析其在不同时间段结合HER2阳性肿瘤细胞的稳定性。用纯化蛋白直接检测经抗原修复的乳腺癌病理组织,与免疫组织化学法检测结果对比。结果在昆虫细胞Sf9中可观察到明显绿色荧光,纯化的融合蛋白相对分子量约60 kDa,浓度为115.5μg/mL,纯度约97%,SKBR3和BT474鉴定为HER2阳性。结合12 h、24 h、48 h后其细胞表面均有明显绿色荧光,而HER2阴性MCF7被洗脱后无荧光,该抗体滴度为1:64,48 h内该荧光抗体仍具有稳定性。携带绿色荧光的融合抗体检测病理组织与IHC法的结果完全一致。表明成功表达的携带绿色荧光的抗HER2单链抗体可特异性检测HER2阳性乳腺癌细胞BT474和SKBR3,在HER2阳性肿瘤细胞和临床病理组织检测上具有应用前景。     

两种人粒酶B嵌合基因的表达及对肿瘤细胞的杀伤作用

通过重组PCR构建了抗HER2单链抗体基因、绿脓杆菌外毒素 (PE)转位肽序列和活性型粒酶B(GrBa)基因相融合的sFv2 3e PEⅡ GrBa基因 ,以及N端包含PE部分转位肽序列的PEⅡ GrBa基因 .将这 2种粒酶B嵌合蛋白基因瞬时转染或稳定转染HeLa细胞及SKBR 3细胞 .通过间接免疫荧光、细胞计数、MTT、ELISA等方法 ,观察到细胞浆中表达的PEⅡ GrBa蛋白直接杀伤其表达细胞 ;而sFv2 3e PEⅡ GrBa表达后被分泌至细胞外 ,对产生它的细胞没有杀伤性 ,但能够特异识别并杀伤HER2阳性肿瘤细胞 .结果表明 ,抗肿瘤表面抗原的抗体能够介导靶向识别 ,转位结构域可以辅助效应分子活化、转位至细胞液并杀伤细胞 ,为肿瘤的靶向治疗提供了新的策略 .     

靶向肽位置影响融合蛋白与细胞结合活性

目的:探讨靶向多肽与标签蛋白(绿色荧光蛋白)的位置关系是否会影响融合蛋白与细胞之间的结合能力。方法:将获得的GE11和LyP1两种靶向多肽分别与增强型绿色荧光蛋白在不同位置融合表达,通过原核系统表达纯化,将纯化的蛋白加入血清饥饿的SMMC-7721肝癌细胞株培养液中,处理3h,通过荧光显微镜观察细胞中绿色荧光蛋白的情况检查融合多肽与细胞的结合情况。结果:绿色荧光蛋白的羧基端和GE11、LyP1多肽分别融合表达,处理细胞后,融合蛋白显示与细胞有很强的结合能力;当GE11、LyP1在绿色荧光蛋白氨基端融合时,融合蛋白几乎不能与细胞结合。在此基础上,检测了多种靶向肽对多种细胞的靶向效应。结论:不合适的融合策略会降低,甚至消除靶向多肽的结合能力;融合大分子量蛋白也会改变靶向肽的靶向效应。因此,当使用靶向多肽携带基因进行研究时,其在融合蛋白中的位置应该非常谨慎。     

抗 HER2-hTNF-α新型免疫毒素的制备及功能研究

HER2/neu 基因在肿瘤中的过度表达使其成为许多肿瘤的标志分子 . 为了增加过度表达 HER2/neu 的肿瘤细胞对肿瘤坏死因子 (TNF) 的敏感性和提高 HER2/neu 抗体的肿瘤杀伤效应,将抗 HER2/neu 单链抗体 C6.5 与人肿瘤坏死因子 hTNF-α融合,构建了 scFvC6.5-hTNF-α融合蛋白,完成了重组蛋白在大肠杆菌中的表达,产率为 400 μg/L 菌液 . 经过亲和层析和柱复性,融合蛋白的纯度达 95％以上 . ELISA 试验表明, scFvC6.5-hTNF-α能够特异结合 HER2/neu 阳性卵巢癌细胞 SKOV-3 和乳腺癌细胞 MCF-7 ,而不结合 HER2/neu 阴性的黑色素瘤细胞 A375. MTT 试验表明, scFvC6.5-hTNF-α能够选择性地杀伤 SKOV-3 和 MCF-7 细胞,而不影响 A375 细胞的生长 . 这种肿瘤细胞特异性杀伤作用提示该免疫毒素具有肿瘤靶向治疗的潜在应用价值 .     

抗汉坦病毒NP scFv基因表达及生物活性分析

诱导已构建的重组质粒pGEX-6P—1—scFv原核表达抗汉坦病毒核衣壳蛋白单链抗体,并用酶免疫实验检测单链抗体生物活性。用IPTG诱导重组原核表达质粒pGEX-6P-1-scFv表达抗汉坦病毒NP单链抗体融合蛋白,经亲和层析纯化,并应用SDS—PAGE电泳检测单链抗体融合蛋白,应用酶免疫实验检测抗NP单链抗体生物学活性。SDS—PAGE电泳检测显示,原核重组质粒pGEX-6P-1-scFv已表达分子量约为56ku的单链抗体融合蛋白;酶免疫实验检测显示,单链抗体具有与汉坦病毒NP抗原特异性结合的生物学活性。结果表明,已构建的原核表达重组质粒pGEX-6P-1-scFv,能够成功表达具有与汉坦病毒NP抗原特异性结合生物学活性的单链抗体。     

膜蛋白LASS2的表达研究

利用多种原核表达系统、真核体外翻译系统和细菌/杆状病毒(Bac to Bac)的昆虫表达系统对一个具有重要生理功能的人的膜蛋白LASS2(Homo sapienslongevity assurance homologue 2 of yeastLAG1)进行表达研究。在原核表达系统中仅能够表达其羧基端胞外区片段却不能表达完整的LASS2蛋白,并制备了该片段的抗体。完整的LASS2蛋白能够在两种真核表达系统中进行表达,SDS-PAGE分析结果表明,表达产物分子量为约28kD的LASS蛋白, Western印迹分析也证实了这一结果, 并利用Ni-NTA树脂亲和层析将该蛋白纯化,纯度达到90%以上。     

慢病毒介导的RNA干涉对乳腺癌SKBR3细胞HER2受体的下调及生长抑制

大约30％的乳腺癌中有表皮生长因子受体家族蛋白HER2的过表达,此类癌症的预后差,恶性程度高。RNA干涉（RNAi）是最近发展起来能特异性抑制哺乳动物细胞中基因表达的新技术。本文在以往获得的能够产生良好基因沉默效应的小干涉RNA（siRNA）的基础上,构建了U6和H1双启动子siRNA表达载体,并转染HER2高表达乳腺癌SKBR3细胞定量测定了其HER2下调效应。随后,siRNA表达盒经LR重组反应被克隆入慢病毒载体中,在成功包装成病毒后,感染SKBR3并经荧光定量PCR、蛋白印迹杂交和流式细胞仪一系列实验证明慢病毒介导的RNAi确实能有效地下调肿瘤抗原HER2的表达。细胞长期增殖实验表明经慢病毒处理后细胞生长得到抑制。我们的研究为进一步阐明HER2与癌症恶化的关系以及发展新的基因治疗药物提供了工具和可能。     

H5N1亚型禽流感病毒血凝素蛋白单链抗体基因的克隆及表达

构建并表达H5N1亚型禽流感病毒血凝素蛋白单链抗体,为禽流感靶向治疗药物的研制制备靶向载体。从分泌血凝素单克隆抗体的杂交瘤细胞株中提取mRNA,采用RT-PCR法扩增出重链和轻链可变区基因,通过SOE-PCR法将重链和轻链通过Linker连接起来构建单链抗体基因,将获得的单链抗体基因装入原核表达载体pET28a(+)中,构建重组质粒并表达,以Western blot鉴定单链抗体的特异性。结果成功构建了单链抗体基因,全长714bp,经原核表达,所构建的单链抗体可与H5亚型禽流感病毒HA蛋白特异结合,为禽流感的靶向治疗奠定了基础。     

基于HER2靶标的抗体偶联药物T-DM1内吞机制研究

目的:研究抗体偶联药物T-DM1与乳腺癌细胞SKBR3表面人表皮生长因子受体2(HER2)的相互作用及内吞机制。方法:采用基于表面等离子共振(SPR)原理的Biacore方法测试配体T-DM1与受体HER2的相互作用,通过流式细胞仪测定药物在体外内吞清除率,利用激光扫描共聚焦显微镜原位检测药物在细胞中的内吞过程。结果:T-DM1与HER2具有高亲和力,ka为6.234×10~6mol/(L·s),kd为3.077×10~(-4)/s,KD为4.936×10~(-11)mol/L,流式细胞实验证明受体与配体的结合具有饱和性;利用免疫荧光方法检测到T-DM1在SKBR3细胞内的消除呈时间-剂量依赖关系,实验表明4 h内荧光强度减低32%,48 h时降低约90%;共聚焦显微镜实验表明T-DM1先与SKBR3细胞表面的HER2受体结合,进入细胞内,反应1 h到达溶酶体,48 h时在显微镜下已消失。结论:T-DM1与HER2具有高亲和力及结合饱和性,在1 h内通过HER2介导内吞进入细胞,随后定位于溶酶体,最后于48 h裂解。     

抗GPC3单链抗体的制备及其在肝细胞癌靶向检测中的应用

磷脂酰肌醇蛋白聚糖3 (Glypican-3,GPC3)是Glypican家族的关键成员,它在肝细胞癌(HCC)的发展、血管生成和转移中起着重要作用。大多数HCC过表达GPC3,而在正常的成人肝脏和良性肝脏病变中几乎检测不到GPC3,因此其可以作为HCC高度特异性的诊断标志和理想的治疗靶标。文中将前期筛选得到的靶向GPC3的单克隆抗体1B11轻重链基因通过柔性肽(Linker)连接,经原核表达纯化,成功获得抗GPC3单链抗体1B11-scFv。通过蛋白印迹法鉴定验证了单链抗体的表达和装配正确;流式细胞术检测其与GPC3阳性细胞株具有与全长抗体相当的结合活性;将单链抗体与近红外荧光探针Cy5.5-NHS偶联,发现其在荷瘤裸鼠体内可精准靶向肿瘤部位,提示其具有实现探针引导下的多方位肝癌精准手术导航的潜力。     

HaSNPV几丁质酶基因在大肠杆菌和昆虫细胞中的表达及其产物对Bt杀虫剂的增效作用

为了探索杆状病毒几丁质酶对微生物杀虫剂的增效作用及其利用途径 ,分别在大肠杆菌和昆虫细胞中表达棉铃虫单粒包埋型核型多角体病毒 (HaSNPV)几丁质酶 .用PCR方法扩增出不含N端信号肽编码序列的几丁质酶基因片段 ,并分别克隆至原核表达载体pET2 8a和重组到杆状病毒BactoBac表达系统 ,在大肠杆菌 (E .coli)BL2 1和粉纹夜蛾 (Trichoplusiani)细胞系Tn 5B1 4中分别进行了表达 .在大肠杆菌中表达量约占细菌总蛋白 15 % ,在昆虫细胞中表达量约占细胞总蛋白10 % .将含有几丁质酶的大肠杆菌和昆虫细胞表达产物添加到苏云金杆菌 (Bt)菌液中一起喂食 2龄家蚕 .结果显示 ,HaSNPV几丁质酶基因的 2种表达产物和Bt杀虫剂的混合物使处理的家蚕的致死时间较对照处理均明显缩短 .昆虫细胞和大肠杆菌表达产物与Bt混合物处理的LT50 分别从 93 5h和 95 1h缩短到 5 6 2h及 6 7 2h ,并且供试家蚕的生长速度明显缓慢 .研究结果表明 ,重组的HaSNPV几丁质酶有望作为Bt杀虫剂的增效剂     

意大利蜜蜂蜂毒磷脂酶A2基因在杆状病毒-昆虫细胞系统中的表达

利用Bac to Bac系统将意大利蜜蜂蜂毒磷脂酶A₂（AmPLA₂）基因cDNA克隆至转移载体pFastBacHTa中,得到pBacHT-AmPLA₂,再将其转化入含穿梭载体Bacmid的受体大肠杆菌DH10Bac中,通过转座作用,得到含AmPLA₂基因的重组病毒rBacmid-AmPLA₂的DNA。提取其基因组DNA,用脂质体介导转染粉纹夜蛾细胞Tn-5B1-4,得到重组病毒rACV-Bac-AmPLA₂。用此重组病毒感染Tn-5B1-4细胞, 在细胞中表达AmPLA₂。SDS-PAGE电泳结果显示,与6×His Tag融合表达的产物蛋白分子量约为18 kD左右,表达量约占细胞总蛋白的5.35%。Western blot印迹显示,融合表达产物能与意大利蜜蜂蜂毒AmPLA₂抗血清发生免疫反应。生物活性测定显示,含表达产物的细胞蛋白粗提物对底物蛋黄的酶活力约为6.13 μmol·min^-1·mg^-1。     

Comparative analysis of GFP(UV)-beta1,3-N-acetylglucosaminyltransferase 2 production in two insect-cell-based expression systems

Active beta1,3-N-acetylglucosaminyltransferase 2 (beta3GnT2) was produced in the baculovirus expression system (BES) and in stably transformed insect Tn-5B1-4 cells. beta3GnT2 was expressed as a secreted fusion protein with GFP(UV) with three different types of signal sequence to enhance the secretion of the fusion protein. In the stably transformed cells, the maximal beta3GnT2 activity differed between isolates, but their secretion efficiencies were similar. The difference between the maximal beta3GnT activities of the isolates studied was considered to be due to the presence of a copy number of the fusion gene, as determined on the basis of the results of Southern blot analysis. The beta3GnT activities of the culture supernatant in BES (Tn-5B1-4 cells) without or with the addition of the protease inhibitor, leupeptin, were 0.68 and 2.01 mU/ml, respectively. The stably transformed Tn-5B1-4 cells (Tn-pXme11) exhibited a beta3GnT activity of 6.83 mU/ml, which was 3.4-fold higher than that observed for BES with the leupeptin addition. The purity of fusion protein purified from the culture supernatant of the Tn-pXme11 was higher than 95% on SDS-PAGE, in contrast with that purified from the culture supernatant of the baculovirus-infected cells which contained low-molecular-weight fragments of the fusion protein. The stably transformed cell line is more suitable than BES for the efficient production of the secretory protein, beta3GnT2.     

中华蜜蜂溶血肽基因在杆状病毒系统中的表达

构建含中华蜜蜂溶血肽基因的重组转移载体pBacHT-GFPTAccM,转化受体菌DH10Bac,得重组穿梭载体Bacmid-GFPTAccM, Lipofectin介导其基因组DNA转染粉纹夜蛾细胞系Tn-5B1-4。SDS-PAGE分析表明,感染重组杆状病毒Bacmid-GFPTAccM的细胞表达产物在约为34 kD处出现特异性条带,其表达量约占细胞总蛋白的3%。Western blotting和细胞表达时相动态分析证明中华蜜蜂溶血肽基因已在粉纹夜蛾细胞系Tn-5B1-4中进行了成功的表达。     

Production and Characterization of Recombinant Mouse Brain-Derived Neurotrophic Factor and Rat Neurotrophin-3 Expressed in Insect Cells

Abstract: Bioactive brain-derived neurotrophic factor (BDNF) and neurotrophin-3 were produced using the baculovirus expression system and purified to homogeneity using ion-exchange and reversed-phase chromatography. Yields of purified neurotrophin-3 (300–500 μg/L) were similar to levels reported for baculovirus-expressed nerve growth factor (NGF), whereas initial yields of BDNF were significantly lower (20–50 μg/L). Improved production of BDNF (150–200 μg/L) was achieved by expressing BDNF from a chimeric prepro-NGF/mature BDNF construct using the Trichoplusia ni insect cell line, Tn-5B1-4. Examination of the distribution of BDNF protein from both the nonchimeric prepro-BDNF and the chimeric prepro-NGF/mature BDNF viruses in Sf-21-and Tn-5B1-4-infected cells suggests a specific deficiency in the Tn-5B1-4 cells in processing the nonchimeric precursor. In addition, the vast majority of the BDNF protein at 2 days after infection was intracellular and insoluble. N-terminal amino acid sequencing of purified recombinant BDNF and neurotrophin-3 demonstrated that the insect cells processed their precursors to the correct N-terminus expected for the mature protein. Bioactivity was characterized in vitro on primary neuronal cultures from the CNS and PNS.     

Improvement of the production of GFPuv-beta1,3-N-acetylglucosaminyltransferase 2 fusion protein using a molecular chaperone-assisted insect-cell-based expression system

A stable Tn-5B1-4 insect cell line co-expressing the recombinant GFPuv-beta1,3-N-acetylglucosaminyltransferase 2 (GFPuv-beta3GnT2) protein fused to a melittin signal sequence with a lectin-like molecular chaperone, human calnexin (hCNX) or human calreticulin (hCRT), was constructed. The expression of either of these molecular chaperones is under the control of a weak promoter, OpMNPV IE2, while that of GFPuv-beta3GnT2 is under the control of Bombyx mori actin promoter. This co-expression system was compared between two different insect cell-baculovirus expression systems: (1) co-infection of the recombinant baculovirus containing a molecular chaperone (AcNPV-hCNX or -hCRT) with a recombinant baculovirus containing GFPuv-beta3GnT2 fused with the melittin signal sequence (AcNPV-me-GGT); (2) infection of AcNPV-me-GGT to a stably expressing cell line for either hCNX or hCRT. In the co-infection system, the intracellular GFPuv-beta3GnT2 expression level was low because of the improved secretion level ratio of the fusion protein, due to the chaperone expression. In the case of infection to the stably expressing cell line for a chaperone, the extracellular GFPuv-beta3GnT2 expression level was similar to the intracellular expression level. This suggests that the amount of expressed chaperone is not sufficient to process beta3GnT2. On the other hand, the co-expression system produced an extracellular beta3GnT activity of 22-23 mU/mL, which was approximately 3.5- and 11-fold higher than those of the stable expression of the fusion gene without the chaperone and the conventional BES with the addition of protease, respectively. The secretion level ratio of the fusion protein of this system increased to 82%, which was approximately 1.5-fold that of any other expression system investigated thus far. These results indicate that the ratio of the expression level of the target gene to that of the chaperone gene may be an important factor in maximizing the production of a target protein. The molecular-chaperone-assisted expression system using a stably transformed insect cell line offers promising prospects for the efficient production of recombinant secretory proteins in insect cells.     

Recombinant protein synthesis in Trichoplusia ni BTI-Tn-5B1-4 insect cell aggregates.

The Trichoplusia ni BTI-Tn-5B1-4 (Tn-5B1-4) insect cell line has received considerable attention as a host for the baculovirus expression vector system. In the present study, suspension cultures were used to compare Tn-5B1-4 cell aggregates and cells selected to grow predominantly as individual cells. No significant difference was found between cell aggregates and cells growing predominantly individually in regard to cell growth rate, glucose consumption and lactate accumulation, and specific recombinant protein synthesis levels. In addition, the levels of recombinant protein synthesis were considerably higher than those produced by the commonly used Spodoptera frugiperda Sf-9 insect cell line.     

High-level expression of human extracellular superoxide dismutase in Escherichia coli and insect cells.

Much is known about the physical properties of the Cu,Zn- and Mn-superoxide dismutases (SODs). However, the biochemical characteristics and pharmacological properties of extracellular (EC)-SOD have been severely limited due to difficulties in obtaining and purifying the enzyme. The EC-SOD cDNA was inserted into the Escherichia coli expression plasmid pET-28a(+) which contains the T7 promoter and transformed into the E. coli BL21(DE3). After induction with 1 mmol/L isopropyl beta-D-thiogalactoside, the recombinant human EC-SOD was highly expressed as inclusion bodies. SDS-PAGE analysis revealed that recombinant EC-SOD accumulated up to 26% of the total soluble protein of E. coli cells. The expression product was purified by a Ni(2+)-IDA-Sepharose 6B column. After the denaturing and refolding processes, the recombinant human EC-SOD retains the specific enzymatic activity of 920 U/mg of the purified product. The gene encoding human EC-SOD mature peptide was also inserted into the donor plasmid pFastBacHTb. After transposition, transfection, and amplification were performed, the recombinant baculoviruses infected the Tn-5B1-4 cells and EC-SOD was highly expressed in Tn-5B1-4 cells. SDS-PAGE and Western blot analysis revealed that the subunit molecular weight of the expression product is 28 kDa. Furthermore, recombinant human EC-SOD retains the enzymatic specific activity of 200 U/mg of the Tn-5B1-4 cell lysates.     

The effect of dissolved oxygen (DO) concentration on the glycosylation of recombinant protein produced by the insect cell-baculovirus expression system.

The effect of dissolved oxygen concentration on human secreted alkaline phosphatase (SEAP) glycosylation by the insect cell-baculovirus expression system was investigated in a well-controlled bioreactor. Oligomannose-type N-linked glycans (i.e., Man2 to Man6 and Man3F) were present in SEAP produced by Spodoptera frusiperda Sf-9 (Sf-9) and Trichoplusia ni BTI-Tn-5B1-4 (Tn-5B1-4) insect cell lines. The relative amounts of the most highly processed glycans (i.e., Man3F and Man2 in the SEAP from Sf-9 and Tn-5B1-4 cells, respectively) were significantly higher at 50% of air saturation than at either 10% or 190% of air saturation. That is, glycan processing was inhibited at both low and high dissolved oxygen concentrations.